Beta cell glucose sensitivity identifies clinical response to disease-modifying therapies initiated at stage 3 type 1 diabetes onset.

Diabetologia · 2026 · PMC13109176 · PMID 41817687

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The results were similar to those obtained using nβGS; however, the results for alefacept did not reach statistical significance using this outcome, while those for ATG/GCSF did.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.